Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease

• Eliyahu V. Khankin ,

  Contributed equally to this work with: Eliyahu V. Khankin, Walter P. Mutter

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Walter P. Mutter ,

  Contributed equally to this work with: Eliyahu V. Khankin, Walter P. Mutter

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Hector Tamez,

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Hai-Tao Yuan,

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• S. Ananth Karumanchi ,

  * E-mail: sananth@bidmc.harvard.edu

  Affiliations Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America, Howard Hughes Medical Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Ravi Thadhani

  Affiliation Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯